Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Articles
Studies on Interactions between Functional Foods or Dietary Supplements and Medicines. I.
Effects of Ginkgo biloba Leaf Extract on the Pharmacokinetics of Diltiazem in Rats
Noriaki OhnishiMayako KusuharaMutsunobu YoshiokaKazuo KurodaAkihiro SogaFumi NishikawaTomokazu KoishiMasato NakagawaSatoshi HoriTsuyoshi MatsumotoMasayuki YamashitaShunsaku OhtaKoji TakaraTeruyoshi Yokoyama
Author information
JOURNAL FREE ACCESS

2003 Volume 26 Issue 9 Pages 1315-1320

Details
Abstract

The effects of Ginkgo biloba leaf extract (GBE), one of the most widely used herbal dietary supplements in Japan, on the pharmacokinetics of diltiazem (DTZ), a typical probe of cytochrome P450 (CYP) 3A, were examined in rats. The simultaneous addition of GBE to small intestine and liver microsomes inhibited the formation of N-demethyl DTZ (MA), an active metabolite of DTZ produced by CYP3A, in a concentration-dependent manner, with an IC50 of about 50 and 182 μg/ml, respectively. This inhibition appeared to be caused, at least in part, by a mechanism-based inhibition. Both the rate of formation of MA and total amount of CYP in intestinal or hepatic microsomes after a single oral pretreatment with GBE (20 mg/kg) decreased transiently. The pretreatment significantly decreased the terminal elimination rate constant and increased the mean residence time, after intravenous administration of DTZ (3 mg/kg). Furthermore, it significantly increased the area under the concentration–time curve and absolute bioavailability after oral administration of DTZ (30 mg/kg). These results indicated that the concomitant use of GBE in rats increased the bioavailability of DTZ by inhibiting both intestinal and hepatic metabolism, at least in part, via a mechanism-based inhibition for CYP3A.

Content from these authors
© 2003 The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top